NCT01667952Completed
Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness
Source: ClinicalTrials.gov · Last updated 7 Mar 2025
Brief summary (registry, in English)
The purpose of this study is to establish a registry of survivors of cancer, tumor, or a related illness.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1068 (actual)
- First submitted
- 15 Aug 2012
- Start date
- Aug 2012
- Primary completion date
- 6 Mar 2025
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT01667952
What you commit to
- Study type: Observational
- Participants enrolled: 1068
- From Aug 2012 to the primary completion date, 6 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of active progression of disease or recurrence
Other
- Neurocognitive deficits that impair ability to give informed consent.
Who the study is looking for
- English speaking
- A personal history of cancer tumor, or a related illness
- Followed in the the Adult Long Term Follow Up Program, Pediatric Long Term Follow Up Program, or Lymphoma Service at MSKCC
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.